Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 7,000 shares at $9.08 ($64K) on 2018-11-21, disclosed to the SEC on 2018-11-26.
Open-market sale of $64k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |